Inogen Slumps 10% While Analysts Boost EPS Estimates 8.9%
Inogen shares have declined 10.0% over the past four weeks and its Relative Strength Index stands at 29.7, placing it in oversold territory. Over the last 30 days sell-side analysts have lifted the consensus EPS estimate by 8.9% and the company holds a Zacks Rank #2 buy rating.
1. Stock's Recent Downtrend and Technical Indicators
INGN shares have slipped 10% over the past four weeks, driving its RSI reading down to 29.7. A momentum oscillator reading below 30 typically signals that selling pressure may be exhausted and a price rebound could be imminent.
2. Analyst Estimate Revisions and Outlook
Sell-side analysts have increased the consensus EPS estimate by 8.9% for the current fiscal year over the past 30 days, reflecting upgraded forecasts. Inogen’s Zacks Rank #2 buy rating underscores the potential for near-term price appreciation as earnings expectations rise.